SlideShare a Scribd company logo
1 of 1
Download to read offline
CORE COMPETENCES AND STRENGTHS
DALIP S. GILL, PhD,
dalipgill@hotmail.com Tel: 732-735-4132
1 Knowledge, and practice of cGMPs, GLPs, and Good Documentation
Practices (Certified Pharmaceutical GMP Professional: ASQ).
2 Subject Matter expertise in Quality Auditing for GMP & ISO standards
(Certified Quality Auditor: ASQ)
3 Write, Review, and Approve pharmaceutical technical documents,
laboratory controls & records, and production batch controls & records to
support product and process development, release of commercial
products, and support CMC sections of regulatory filings.
4 In depth working knowledge of Laboratory operations of method
development, method validation, and analytical cGMP testing of
pharmaceutical materials [Raw materials, Process Intermediates, Drug
Substance, and Drug Product] .
5 Stability testing to support Pharmaceutical Product Development, writing
Stability Protocols, analyzing data, and writing Stability Reports.
6 Implement, execute, and sustain elements of Pharmaceutical Quality
System (change control, audits, deviations, investigations, root cause
analysis, CAPA).
7 Solid scientific background in Biochemistry, Chemistry, Molecular
Biology, Cell Biology, and Virology (List of Publications).
8 Current with knowledge of relevant ICH, EU, and FDA guidance
documents, CFR 21, Parts 210, 211, 58, 11, & 820, Microsoft Office,
Statistics, and LIMS.
9 Hands-on as well as executive level 25 years solid experience of working in
regulated major pharmaceutical and biotechnology companies with branded
and un-branded biologics and health care pharmaceutical products.
DALIP S. GILL, PhD, CPGP: ASQ, and CQA:ASQ

More Related Content

What's hot

How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
 
Covering Letter for QA Specialist,2013
Covering Letter for QA Specialist,2013Covering Letter for QA Specialist,2013
Covering Letter for QA Specialist,2013Manohar Patil
 
OPDIVO® Biosimilar CMC Analytical Solutions
OPDIVO® Biosimilar CMC Analytical SolutionsOPDIVO® Biosimilar CMC Analytical Solutions
OPDIVO® Biosimilar CMC Analytical SolutionsCovance
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Trainingguestaa38de
 
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6Rx Research Services CRO
 
Quality Assurance Services
Quality Assurance ServicesQuality Assurance Services
Quality Assurance ServicesGVK Biosciences
 
KEYTRUDA® Biosimilar CMC Analytical Solutions
KEYTRUDA® Biosimilar CMC Analytical SolutionsKEYTRUDA® Biosimilar CMC Analytical Solutions
KEYTRUDA® Biosimilar CMC Analytical SolutionsCovance
 
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Peter Dellva
 
The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...
The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...
The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...Obaid Ali / Roohi B. Obaid
 
Form 483 Ranbaxy (Mohali Facility)
Form 483  Ranbaxy (Mohali Facility)Form 483  Ranbaxy (Mohali Facility)
Form 483 Ranbaxy (Mohali Facility)Gaurav kumar
 
Good manufacturing practices himanshu
Good manufacturing practices himanshuGood manufacturing practices himanshu
Good manufacturing practices himanshuhimanshu kamboj
 
ISA 2nd process analytical technology conference
ISA 2nd process analytical technology conferenceISA 2nd process analytical technology conference
ISA 2nd process analytical technology conferenceMike Nager
 
gkaur_Resume_CMA
gkaur_Resume_CMAgkaur_Resume_CMA
gkaur_Resume_CMAGagan Kaur
 

What's hot (20)

How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
 
Jason Gillette CV
Jason Gillette CVJason Gillette CV
Jason Gillette CV
 
Covering Letter for QA Specialist,2013
Covering Letter for QA Specialist,2013Covering Letter for QA Specialist,2013
Covering Letter for QA Specialist,2013
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
 
Ghazala Rahim (1)
Ghazala Rahim (1)Ghazala Rahim (1)
Ghazala Rahim (1)
 
Drug Quality .. A Matter of Deep Concern
Drug Quality .. A Matter of Deep ConcernDrug Quality .. A Matter of Deep Concern
Drug Quality .. A Matter of Deep Concern
 
OPDIVO® Biosimilar CMC Analytical Solutions
OPDIVO® Biosimilar CMC Analytical SolutionsOPDIVO® Biosimilar CMC Analytical Solutions
OPDIVO® Biosimilar CMC Analytical Solutions
 
FDA Regulations
FDA RegulationsFDA Regulations
FDA Regulations
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Training
 
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
 
Epitome Corporate PPT
Epitome Corporate PPTEpitome Corporate PPT
Epitome Corporate PPT
 
Quality Assurance Services
Quality Assurance ServicesQuality Assurance Services
Quality Assurance Services
 
KEYTRUDA® Biosimilar CMC Analytical Solutions
KEYTRUDA® Biosimilar CMC Analytical SolutionsKEYTRUDA® Biosimilar CMC Analytical Solutions
KEYTRUDA® Biosimilar CMC Analytical Solutions
 
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
 
Usp 2008track2combined
Usp 2008track2combinedUsp 2008track2combined
Usp 2008track2combined
 
The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...
The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...
The Evolving Quality Expectations & Reshaping Strategy of Controls in Pharmac...
 
Form 483 Ranbaxy (Mohali Facility)
Form 483  Ranbaxy (Mohali Facility)Form 483  Ranbaxy (Mohali Facility)
Form 483 Ranbaxy (Mohali Facility)
 
Good manufacturing practices himanshu
Good manufacturing practices himanshuGood manufacturing practices himanshu
Good manufacturing practices himanshu
 
ISA 2nd process analytical technology conference
ISA 2nd process analytical technology conferenceISA 2nd process analytical technology conference
ISA 2nd process analytical technology conference
 
gkaur_Resume_CMA
gkaur_Resume_CMAgkaur_Resume_CMA
gkaur_Resume_CMA
 

Similar to Core Competences and Strengths in Pharmaceutical Quality

Presentation China And Usa July 2011
Presentation   China And Usa July 2011Presentation   China And Usa July 2011
Presentation China And Usa July 2011roeandjoe
 
Laboratory and Pharmaceutical Quality Assurance Expert
Laboratory and Pharmaceutical Quality Assurance ExpertLaboratory and Pharmaceutical Quality Assurance Expert
Laboratory and Pharmaceutical Quality Assurance ExpertMathias Atelefack
 
DRA syllabus Sem 1 book referenced mentioned
DRA syllabus Sem 1 book referenced mentionedDRA syllabus Sem 1 book referenced mentioned
DRA syllabus Sem 1 book referenced mentionedDeepa563153
 
DRA syllabus Sem 1 for sppu reference and books ref
DRA syllabus Sem 1 for sppu reference and books  refDRA syllabus Sem 1 for sppu reference and books  ref
DRA syllabus Sem 1 for sppu reference and books refDeepa563153
 
Concept of qa, qc, gmp 112070804010
Concept of qa, qc, gmp  112070804010Concept of qa, qc, gmp  112070804010
Concept of qa, qc, gmp 112070804010Patel Parth
 
Reg & Qa GMP
Reg & Qa GMPReg & Qa GMP
Reg & Qa GMPLouise666
 
Qa & Gmp 29 May2010
Qa & Gmp 29 May2010Qa & Gmp 29 May2010
Qa & Gmp 29 May2010Louise666
 
Alice - Resume 25NOV16
Alice - Resume 25NOV16Alice - Resume 25NOV16
Alice - Resume 25NOV16Alice Gray
 
Regulatory Compliance in Pharmaceutical DevelopmentGL.docx
Regulatory Compliance in Pharmaceutical DevelopmentGL.docxRegulatory Compliance in Pharmaceutical DevelopmentGL.docx
Regulatory Compliance in Pharmaceutical DevelopmentGL.docxsodhi3
 
coco quality management resume dec102014
coco quality management resume dec102014coco quality management resume dec102014
coco quality management resume dec102014Charlie Coco
 
Jose d santiago 619.doc
Jose d  santiago 619.docJose d  santiago 619.doc
Jose d santiago 619.docJose Santiago
 
Quality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llQuality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llJafarali Masi
 
OscarLara_resume_2015current
OscarLara_resume_2015currentOscarLara_resume_2015current
OscarLara_resume_2015currentOscar Lara
 

Similar to Core Competences and Strengths in Pharmaceutical Quality (20)

Presentation China And Usa July 2011
Presentation   China And Usa July 2011Presentation   China And Usa July 2011
Presentation China And Usa July 2011
 
Laboratory and Pharmaceutical Quality Assurance Expert
Laboratory and Pharmaceutical Quality Assurance ExpertLaboratory and Pharmaceutical Quality Assurance Expert
Laboratory and Pharmaceutical Quality Assurance Expert
 
KC
KCKC
KC
 
CVQC_SP
CVQC_SPCVQC_SP
CVQC_SP
 
DRA syllabus Sem 1 book referenced mentioned
DRA syllabus Sem 1 book referenced mentionedDRA syllabus Sem 1 book referenced mentioned
DRA syllabus Sem 1 book referenced mentioned
 
DRA syllabus Sem 1 for sppu reference and books ref
DRA syllabus Sem 1 for sppu reference and books  refDRA syllabus Sem 1 for sppu reference and books  ref
DRA syllabus Sem 1 for sppu reference and books ref
 
CHRIS RESUME v3 11-21-14
CHRIS RESUME v3 11-21-14CHRIS RESUME v3 11-21-14
CHRIS RESUME v3 11-21-14
 
Concept of qa, qc, gmp 112070804010
Concept of qa, qc, gmp  112070804010Concept of qa, qc, gmp  112070804010
Concept of qa, qc, gmp 112070804010
 
Reg & Qa GMP
Reg & Qa GMPReg & Qa GMP
Reg & Qa GMP
 
Qa & Gmp 29 May2010
Qa & Gmp 29 May2010Qa & Gmp 29 May2010
Qa & Gmp 29 May2010
 
Alice - Resume 25NOV16
Alice - Resume 25NOV16Alice - Resume 25NOV16
Alice - Resume 25NOV16
 
Curriculum Vitae
Curriculum VitaeCurriculum Vitae
Curriculum Vitae
 
Regulatory Compliance in Pharmaceutical DevelopmentGL.docx
Regulatory Compliance in Pharmaceutical DevelopmentGL.docxRegulatory Compliance in Pharmaceutical DevelopmentGL.docx
Regulatory Compliance in Pharmaceutical DevelopmentGL.docx
 
coco quality management resume dec102014
coco quality management resume dec102014coco quality management resume dec102014
coco quality management resume dec102014
 
jos cv quality July 2016
jos cv quality July 2016jos cv quality July 2016
jos cv quality July 2016
 
revised resume 2014
revised resume 2014revised resume 2014
revised resume 2014
 
Jose d santiago 619.doc
Jose d  santiago 619.docJose d  santiago 619.doc
Jose d santiago 619.doc
 
Quality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llQuality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY ll
 
Yaara Dromi
Yaara DromiYaara Dromi
Yaara Dromi
 
OscarLara_resume_2015current
OscarLara_resume_2015currentOscarLara_resume_2015current
OscarLara_resume_2015current
 

Core Competences and Strengths in Pharmaceutical Quality

  • 1. CORE COMPETENCES AND STRENGTHS DALIP S. GILL, PhD, dalipgill@hotmail.com Tel: 732-735-4132 1 Knowledge, and practice of cGMPs, GLPs, and Good Documentation Practices (Certified Pharmaceutical GMP Professional: ASQ). 2 Subject Matter expertise in Quality Auditing for GMP & ISO standards (Certified Quality Auditor: ASQ) 3 Write, Review, and Approve pharmaceutical technical documents, laboratory controls & records, and production batch controls & records to support product and process development, release of commercial products, and support CMC sections of regulatory filings. 4 In depth working knowledge of Laboratory operations of method development, method validation, and analytical cGMP testing of pharmaceutical materials [Raw materials, Process Intermediates, Drug Substance, and Drug Product] . 5 Stability testing to support Pharmaceutical Product Development, writing Stability Protocols, analyzing data, and writing Stability Reports. 6 Implement, execute, and sustain elements of Pharmaceutical Quality System (change control, audits, deviations, investigations, root cause analysis, CAPA). 7 Solid scientific background in Biochemistry, Chemistry, Molecular Biology, Cell Biology, and Virology (List of Publications). 8 Current with knowledge of relevant ICH, EU, and FDA guidance documents, CFR 21, Parts 210, 211, 58, 11, & 820, Microsoft Office, Statistics, and LIMS. 9 Hands-on as well as executive level 25 years solid experience of working in regulated major pharmaceutical and biotechnology companies with branded and un-branded biologics and health care pharmaceutical products. DALIP S. GILL, PhD, CPGP: ASQ, and CQA:ASQ